E
Ultragenyx Pharmaceutical Inc. RARE
$39.34 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 29.42% 42.27% 35.75% 8.30% 23.27%
Total Other Revenue -- -- -- -- --
Total Revenue 29.42% 42.27% 35.75% 8.30% 23.27%
Cost of Revenue 8.21% 91.33% 4.53% 10.15% 275.01%
Gross Profit -3.15% 36.07% 46.27% -12.56% -632.50%
SG&A Expenses 7.37% 7.25% -0.98% 1.98% 5.47%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 15.12% 11.65% 2.78% 7.69% 0.19%
Operating Income -0.19% 9.04% 21.35% -7.30% 16.19%
Income Before Tax -5.13% 16.22% 17.82% -4.13% 17.22%
Income Tax Expenses 99.49% -53.38% 17.21% -8.08% -155.13%
Earnings from Continuing Operations -8.28% 16.37% 17.66% -4.09% 18.86%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -8.28% 16.37% 17.66% -4.09% 18.86%
EBIT -0.19% 9.04% 21.35% -7.30% 16.19%
EBITDA 0.56% 10.64% 24.61% -5.13% 19.08%
EPS Basic 8.20% 37.24% 32.58% 13.09% 29.83%
Normalized Basic EPS 13.19% 36.24% 34.87% 10.97% 28.21%
EPS Diluted 8.20% 37.24% 32.58% 12.88% 29.83%
Normalized Diluted EPS 13.19% 36.24% 34.87% 10.97% 28.21%
Average Basic Shares Outstanding 17.95% 33.25% 22.12% 19.78% 15.63%
Average Diluted Shares Outstanding 17.95% 33.25% 22.12% 19.78% 15.63%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings